Background illustration for clinical trials search

Ulcerative Colitis Clinical Trials

Browse 237 Ulcerative Colitis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
FeaturedActive & Responsive

Crohn's Disease and Ulcerative Colitis Studies for Adults With Hard-to-Treat Symptoms

for
Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
Location: Yonkers NY, Fayetteville NC, Monroe NC, Tampa FL,

Sex: All

Age: 18 - 70+

Recruiting
Active & Responsive

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

for
Ulcerative Colitis
Location: London, Boston MA, Providence RI, Trois-Rivieres,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07186101

Phase 2, Recruiting
Active & Responsive

Genome Analysis Across Populations in Inflammatory Bowel Disease

for
Ulcerative Colitis, Healthy, Crohn Disease,
Location: Toronto
Sponsor: Mount Sinai Hospital, Canada

Sex: All

Age: 0+

Code: NCT06042387

Recruiting
Active & Responsive

Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

for
Ulcerative Colitis, Inflammatory Bowel Diseases,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT07401680

Phase 1, Recruiting
Active & Responsive

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for
Autoimmune Disease, Crohn Disease, Dermatomyositis,
Location: Boston MA, New Haven CT, Mineola NY, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03816345

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

for
Inflammatory Bowel Disease (IBD), Crohn's Disease,
Location: New York NY, Chapel Hill NC
Sponsor: Mercy Medical Center

Sex: All

Age: 18+

Code: NCT06750731

Recruiting
Active & Responsive

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07237516

Recruiting
Active & Responsive

Confirmatory Clinical Study in Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: Fayetteville NC, Palmetto Bay FL, Miami FL,
Sponsor: MRM Health NV

Sex: All

Age: 16+

Code: NCT07296315

Phase 2, Recruiting
Active & Responsive

Impact of Prebiotics in Ulcerative Colitis

for
Crohn Disease, Ulcerative Colitis
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 70+

Code: NCT06495658

Recruiting
Active & Responsive

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

for
Ulcerative Colitis Chronic Mild,
Location: Plantation FL, Miami FL, Tampa FL, Rochester MN,
Sponsor: Rise Therapeutics LLC

Sex: All

Age: 18 - 65

Code: NCT05666960

Phase 1, Recruiting
Active & Responsive

Microbiome-targeted Diet Therapy in Ulcerative Colitis

for
Ulcerative Colitis
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18+

Code: NCT07520461

Recruiting
Active & Responsive

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

for
Crohn Disease (CD), Ulcerative Colitis (UC)
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT07303686

Recruiting
Active & Responsive

Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis

for
Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC)
Location: Hamilton
Sponsor: McMaster University

Sex: All

Age: 18+

Code: NCT07341282

Phase 2, Recruiting
Active & Responsive

Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis

for
Colitis, Ulcerative
Location: Hamilton
Sponsor: McMaster University

Sex: All

Age: 18 - 64

Code: NCT06660693

Phase 3, Recruiting
Active & Responsive

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222800

Phase 3, Recruiting
Active & Responsive

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

for
Rare Disorders, Undiagnosed Disorders,
Location: Sioux Falls SD
Sponsor: Sanford Health

Sex: All

Age: 0+

Code: NCT01793168

Recruiting
Active & Responsive

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: New York NY, Philadelphia PA, Bethesda MD,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 3+

Code: NCT02523118

Recruiting
Active & Responsive

Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children

for
Functional Abdominal Pain Disorders,
Location: Houston TX, Austin TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 7 - 12

Code: NCT07222943

Recruiting
Active & Responsive

Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience

for
Gastrointestinal Symptoms, Skin Quality
Location: Fort Collins CO
Sponsor: Colorado State University

Sex: All

Age: 18 - 70+

Code: NCT07816809

Recruiting
Active & Responsive

Study of DISC-0974-201 in Participants With IBD and Anemia

for
Inflammatory Bowel Disease (IBD), Anemia,
Location: Providence RI, Miami Lakes FL, Miami FL, Doral FL,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT07368972

Phase 2, Recruiting

What is ulcerative colitis?

Ulcerative colitis, or UC, is a form of inflammatory bowel disease. Abnormal reactions of the immune system cause inflammation and open sores called ulcers on the inner lining of the large intestine, meaning the colon and the rectum. That leads to diarrhea, blood in the stool, and belly pain. UC doesn't only affect the colon either. It's linked to higher rates of arthritis, and specifically to ankylosing spondylitis and psoriasis, conditions doctors call extraintestinal manifestations of the disease. It most often starts between ages 15 and 30, though it can begin at any age. About 1.25 million Americans have been diagnosed with UC, which makes it the more common form of IBD in adults, slightly ahead of Crohn's disease.

Research in this field has its own shape. Most UC studies check whether a drug worked with a colonoscopy or sigmoidoscopy at set visits, because it is not enough for a person to feel better, a camera has to show the colon lining healing. That is also why UC trials run in two stages, one to see if the drug works fast and a longer one to see if the effect lasts. And there is a gap the field wants to close: UC affects every racial and ethnic group, but Black, Hispanic, and Asian patients are still underrepresented in IBD research, so many studies actively welcome them.

Article preview image

Interested in learning more about Entyvio? Read our guide: Entyvio Side Effects: A Patient Guide

Entyvio Not Working Well Enough? Side Effects, Timing, and Next Steps

Forms and severity of ulcerative colitis, and why they matter for trials

Can ulcerative colitis be cured?

Is ulcerative colitis genetic?

Types of trials used for ulcerative colitis

Who can participate in ulcerative colitis clinical trials?

How to enroll in an ulcerative colitis clinical trial